Astrazeneca Plc Adrhedged Etf Profile
| AZNH Etf | 45.20 0.13 0.29% |
Performance0 of 100
| Odds Of DistressLess than 9
|
AstraZeneca PLC is trading at 45.20 as of the 30th of November 2024. This is a 0.29 percent increase since the beginning of the trading day. The etf's open price was 45.07. AstraZeneca PLC has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for AstraZeneca PLC ADRhedged are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
AstraZeneca PLC is entity of United States. It is traded as Etf on BATS exchange. More on AstraZeneca PLC ADRhedged
Moving against AstraZeneca Etf
AstraZeneca Etf Highlights
| Thematic Ideas | (View all Themes) |
| Business Concentration | Single Stock ETFs, Strategy ETFs, Health (View all Sectors) |
| Issuer | Precidian Funds |
| Inception Date | 2024-10-01 |
| Benchmark | AstraZeneca PLC (NASDAQ: AZN) |
| Entity Type | Regulated Investment Company |
| Asset Type | Equity |
| Category | Strategy |
| Focus | Single Stock |
| Market Concentration | Developed Markets |
| Region | North America |
| Administrator | The Bank of New York Mellon Corporation |
| Advisor | Precidian Funds, LLC |
| Custodian | The Bank of New York Mellon Corporation |
| Distributor | Foreside Fund Services, LLC |
| Portfolio Manager | Daniel McCabe, Mark Criscitello |
| Transfer Agent | The Bank of New York Mellon Corporation |
| Exchange | Cboe BZX Exchange, Inc. |
| Market Maker | Citadel |
| Total Expense | 0.19 |
| Management Fee | 0.17 |
| Country Name | USA |
| Code | AZNH |
| Updated At | 29th of November 2024 |
| Name | AstraZeneca PLC ADRhedged |
| Currency Name | US Dollar |
| Currency Code | USD |
| Open Figi | BBG01Q37F602 |
| Type | ETF |
AstraZeneca PLC ADRhedged [AZNH] is traded in USA and was established null. The fund is listed under Health. The entity is thematically classified as Single Stock ETFs. AstraZeneca PLC ADRhedged presently have in assets under management (AUM).
Check AstraZeneca PLC Probability Of Bankruptcy
AstraZeneca PLC ADRhedged Risk Profiles
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AstraZeneca PLC. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.51) | |||
| Treynor Ratio | (79.00) |
AstraZeneca PLC Against Markets
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADRhedged. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
The market value of AstraZeneca PLC ADRhedged is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.